Cordyceps sinensis mycelium protects mice from group A streptococcal infection.
Kuo, Chih-Feng 1; Chen, Cheng-Chih 2; Luo, Yueh-Hsia 2; Huang, Robert Y 3; Chuang, Woei-Jer 4; Sheu, Chia-Chin 5; Lin, Yee-Shin 2
Journal of Medical Microbiology.
54(8):795-802, August 2005.
(Format: HTML, PDF)
Group A streptococcus (GAS) infection can cause severe invasive diseases, including necrotizing fasciitis and streptococcal toxic shock syndrome. Cordyceps sinensis, a Chinese herbal medicine, is an immunomodulator. In this study the air-pouch bacterial inoculation model was used to investigate the protective efficacy of C. sinensis mycelium extract against GAS infection. Force-feeding mice with C. sinensis mycelium extract for 3 consecutive days before GAS infection increased the survival rate and reduced local skin-tissue injury compared with mice fed PBS. Bacterial numbers in the air pouch exudates from C. sinensis-treated mice were lower than those from PBS-treated mice. Blood and organs in PBS-treated mice showed bacterial dissemination, but those in C. sinensis-treated mice did not. Three days of pretreatment with C. sinensis extract followed by C. sinensis treatment every other day after GAS infection resulted in 100 % survival. The post-GAS-infection levels of aspartate aminotransferase, alanine aminotransferase and blood urea nitrogen in the sera of C. sinensis-treated mice were lower than those of PBS-treated mice. Taken together, these results show that C. sinensis mycelium extract protects by decreasing bacterial growth and dissemination, thereby increasing mouse survival rate. IL-12 and IFN-[gamma] expression and macrophage phagocytic activity also increased after C. sinensis treatment.
Copyright (C) 2005 Society for General Microbiology